Literature DB >> 1429185

Renal dysfunction associated with infection of Leptospira interrogans in a horse.

T J Divers1, T D Byars, S J Shin.   

Abstract

Renal failure associated with infection of Leptospira interrogans was detected in a horse. Fever, leukocytosis, pyuria, isosthenuria, and azotemia were suggestive of an inflammatory urinary tract disease. Despite persistent pyuria, no bacteria were found during routine microscopic examinations or bacteriologic culturing of urine. A fluorescent antibody examination of the urine was positive for L interrogans. Serologic testing during a 6-month period, supported an acute infection with L interrogans serovar pomona. Treatment with intravenously administered fluids and antimicrobials resulted in clinical recovery. Leptospira interrogans serovar pomona has been reported as causing fever, uveitis, or abortion in horses.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1429185

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  4 in total

1.  Development of an enzyme-linked immunosorbent assay using a recombinant LigA fragment comprising repeat domains 4 to 7.5 as an antigen for diagnosis of equine leptospirosis.

Authors:  Weiwei Yan; Muhammad Hassan Saleem; Patrick McDonough; Sean P McDonough; Thomas J Divers; Yung-Fu Chang
Journal:  Clin Vaccine Immunol       Date:  2013-05-29

2.  Serodiagnosis of equine leptospirosis by enzyme-linked immunosorbent assay using four recombinant protein markers.

Authors:  Cuilian Ye; Weiwei Yan; Patrick L McDonough; Sean P McDonough; Hussni Mohamed; Thomas J Divers; Yung-Fu Chang; Zhibang Yang
Journal:  Clin Vaccine Immunol       Date:  2014-01-22

3.  Titers to Leptospira species in horses in Alberta.

Authors:  V W Lees; S P Gale
Journal:  Can Vet J       Date:  1994-10       Impact factor: 1.008

4.  Leptospira seroprevalence and associations between seropositivity, clinical disease and host factors in horses.

Authors:  V Båverud; A Gunnarsson; E Olsson Engvall; P Franzén; A Egenvall
Journal:  Acta Vet Scand       Date:  2009-03-30       Impact factor: 1.695

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.